About this trial
glaucoma is prevalent among obstructive sleep apnea (OSA). contnous passive airway pressure is main treatment of OSA. lifestyle corrections also recommended
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Obstructive sleep apnea patients
obese patients
glaucoma (open angle form with ocular hyoertension)
Disqualifiers
None
Trial design
Parallel
Treatments tested in this trial
lifetyle corrections and CPAP
Behavioraltwenty glaucoma patients (high tension priamry open angle form) with OSA, intraocular pressure more than 21 mmHg, and obesity will be involved in group I will apply CPAP during night sleeping daily for three month. group I will apply lifestyle corrections (low calories diet intake and 3-session per-week 40-minute treadmill walking for three month.
CPAP
Other interventiontwenty glaucoma patients (high tension priamry open angle form) with OSA, intraocular pressure more than 21 mmHg, and obesity will be involved in group II will apply CPAP during night sleeping daily for three month.
Treatment groups
Trial outcomes
Primary outcomes
Intraocular pressure
it will be measured by tonometery
Secondary outcomes
apnea hypopnea index
it is an indicator on numbe rof apnea during sleep
Epowrth sleepiness scale
a questioanire assess rate of sleepiness
body mass index
it assesed on empty bladder and bowel
waist circumference
it will be assesed at umbilical level
Sponsors and contacts
Click on the lead sponsor to view all of their trials.